$1.5m funding for breast cancer project:
This article was originally published in Clinica
An investigation into new ways to detect breast cancer is underway with joint funding of $1.5 million from Hyal Pharmaceutical and the Natural Sciences and Engineering Research Council of Canada. Researchers at McMaster University, the University of Toronto and the Toronto Hospital, will attempt to find out if hyaluronic acid used with MRI in mammography will result in more reliable detection of early-stage breast cancer. Hyaluronic acid binds to breast cancer cells and will be used as a carrier for MRI imaging agents.